135 related articles for article (PubMed ID: 10851575)
21. [Obesity and risk of cancer in the woman].
Schindler AE
Zentralbl Gynakol; 1998; 120(5):235-40. PubMed ID: 9629630
[TBL] [Abstract][Full Text] [Related]
22. Potential benefits of estrogens and progestogens on breast cancer.
Schneider HP; Jackisch C
Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
[TBL] [Abstract][Full Text] [Related]
23. Environmentally related cancer in women.
Environ Health Perspect; 1993 Jun; 101(2):110-1. PubMed ID: 8354190
[No Abstract] [Full Text] [Related]
24. Nonbreast second malignancies after treatment of primary breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
[TBL] [Abstract][Full Text] [Related]
25. IPPF statement on oral contraceptives and cancer of the breast.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374
[TBL] [Abstract][Full Text] [Related]
26. The pill and the breast.
Drife JO
IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
[TBL] [Abstract][Full Text] [Related]
27. Background review paper on total fat, fatty acid intake and cancers.
Gerber M
Ann Nutr Metab; 2009; 55(1-3):140-61. PubMed ID: 19752540
[No Abstract] [Full Text] [Related]
28. Timing of pregnancy and the risk of epithelial ovarian cancer.
Whiteman DC; Siskind V; Purdie DM; Green AC
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
[TBL] [Abstract][Full Text] [Related]
29. Cancer surveillance during HRT.
Palacios S
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():93-8. PubMed ID: 7874192
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic analysis of breast and gynecologic cancers.
Hulka BS
Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587
[TBL] [Abstract][Full Text] [Related]
31. Endogenous and exogenous endocrine factors.
Henderson BE
Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490
[TBL] [Abstract][Full Text] [Related]
32. [Cross-sectional epidemiological research on genital and breast cancers in the North-East region of Romania].
Matei M; Olteanu S; Ciolpan C; Azoicăi D
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):775-85. PubMed ID: 20201268
[TBL] [Abstract][Full Text] [Related]
33. The role of cooked food mutagens as possible etiological agents in human cancer. A critical appraisal of recent epidemiological investigations.
de Meester C; Gerber GB
Rev Epidemiol Sante Publique; 1995; 43(2):147-61. PubMed ID: 7732201
[TBL] [Abstract][Full Text] [Related]
34. Diet, hormones, and cancer.
Rose DP
Annu Rev Public Health; 1993; 14():1-17. PubMed ID: 8391818
[No Abstract] [Full Text] [Related]
35. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
Kok VC; Tsai HJ; Su CF; Lee CK
Int J Gynecol Cancer; 2015 Jul; 25(6):968-76. PubMed ID: 25893280
[TBL] [Abstract][Full Text] [Related]
36. Ovarian and endometrial cancers.
Mant JW; Vessey MP
Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
[TBL] [Abstract][Full Text] [Related]
37. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
38. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
Jamin C; Bourg F; Legeai J; Senoussi S
Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
[TBL] [Abstract][Full Text] [Related]
39. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
[TBL] [Abstract][Full Text] [Related]
40. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
